FY 2016 Government Performance and Results Act (GPRA)Tobacco Cessation and Childhood Weight Control decreased from 2015 performance but still met 2016 targets Pneumococcal Vaccination,

FY 2016 Government Performance and Results Act (GPRA) INDIAN HEALTH SERVICE (IHS) GPRA PERFORMANCE RESULTS

Introduction IHS clinical GPRA results are calculated from the Clinical Reporting System (CRS) Class 1 software module installed locally on the Resource and Patient Management System (RPMS), IHS’s electronic health record.

The CRS measure logic is located here

Each clinical measure has two graphs: ◦ the current national performance result and historical data

◦ IHS !rea graphs comparing the current reporting year to the previous year for each of IHS’s twelve !reaOffices.

https://www.ihs.gov/crs/includes/themes/newihstheme/display_objects/documents/crsv16/GPRAMeasuresV161.pdf

Area Abbreviations Area

Alaska

Albuquerque

Bemidji

Billings

California

Great Plains

Nashville

Navajo

Oklahoma

Phoenix

Abbreviation

ALA

ALB

BEM

BIL

CAL

GPA

NAS

NAV

OKL

PHX

POR Portland

TUC Tucson

Acronym

NPIRS

AI/AN

A1c

BMI

BP

CHD

CVD

DV/IPV

GPRAMA

HP

LDL

Definition

National Patient Information Reporting System

American Indian/Alaska Native

Hemoglobin A1c

Body Mass Index

Blood Pressure

Coronary Heart Disease

Cardiovascular Disease

Domestic Violence/Intimate Partner Violence

Government Performance and Results Act Modernization Act

Healthy People

Low Density Lipoprotein

MH Million Hearts

Acronym Definitions

GPRA 2016 Results Summary Of the 24 measures that IHS/Tribal programs reported in FY 2016: ◦ 15 measures met their targets

10 measures exceeded FY 2015 results◦8 measures decreased from FY 2015 results◦4 measures were new for FY 2016 and had baseline targets◦2 measures had revised logic in FY 2016 and had baseline targets◦

Most (6 of 8) of the measures that decreased did not meet targets, however:

◦ Tobacco Cessation and Childhood Weight Control decreased from 2015 performance butstill met 2016 targets◦ Pneumococcal Vaccination, Mammography, and Controlling High Blood Pressure

(MH) exceeded 2015 results but did not meet 2016 targets

◦2 GPRAMA measures (Depression and CVD) improved and met targets while the other two(Good Glycemic and Childhood Immunizations) decreased and did not meet targets

FY 2016 IHS/Tribal Results Summary In FY 2016, 10 measures improved over FY 2015 performance

Measure FY 2015 Q4 FY 2016 Q4 % Improvement

CVD Comprehensive Assessment* 55.0% 65.7% 10.7%*

Controlled BP <140/90* 62.5% 68.3% 5.8%*

Dental Sealants 16.3% 18.1% 1.8%

Topical Fluorides 29.4% 31.1% 1.7%

Pneumococcal Vaccination 65+ 84.9% 86.4% 1.5%

Nephropathy Assessed 62.0% 63.3% 1.3%

Colorectal Cancer Screening 38.6% 39.6% 1.0%

Controlling High BP (MH) 58.5% 59.2% 0.7%

Depression Screening 67.4% 67.9% 0.5%

Mammography 54.5% 54.8% 0.3%

*measures with logic changes in FY 2016 but no baseline target

FY 2016 IHS/Tribal Results Summary

In FY 2016, 8 measures decreased compared to FY 2015 performance

Measure FY 2015 Q4 FY 2016 Q4 % Decrease

Retinopathy Exam* 61.3% 59.1% 2.2%*

Tobacco Cessation* 52.1% 50.4% 1.7%*

Childhood Immunizations 73.3% 72.3% 1.0%

Good Glycemic Control 47.4% 46.9% 0.5%

Dental Access 29.2% 28.7% 0.5%

Breastfeeding Rates 35.7% 35.2% 0.5%

Childhood Weight Control 21.8% 22.3% 0.5%

Cervical (Pap) Screening 54.9% 54.8% 0.1%

*measures with logic changes in FY 2016 but no baseline target

Diabetes: Good Glycemic Control AI/AN patients with diabetes who have maintained Good A1c control (<8) during the past

year.

PER

CEN

T

100

80

60

40

20

CRS Diabetes Audit

32 31 32 31.9 33.2

48.3 48.6 47.4 46.9

39

36 36 37

2008 2009 2010 2011 2012 2013 2014 2015 2016

*

*Prior to FY 2013, this measure tracked the percentage of patients with ideal glycemic control (HbA1c <7 ).

0

Diabetes: Good Glycemic Control 100%

0%

20%

40%

60%

80%

ALA ALB BEM BIL CAL GPA NAS NAV OKL PHX POR TUC

FY16 59.8% 48.8% 46.2% 45.9% 51.1% 42.8% 42.7% 44.7% 57.9% 40.4% 49.7% 43.3%

FY15 60.5% 47.5% 40.6% 42.5% 50.3% 42.9% 41.8% 45.0% 58.7% 40.2% 49.7% 42.1%

N 2457 8704 4321 5665 4839 11997 5743 20104 17107 20629 5973 3139

Diabetes: Blood Pressure Control AI/AN patients with diabetes who have maintained BP control (<140/90) during the past year.

PER

CEN

T

CRS Diabetes Audit

100

80

60

40

20

0

2008 2009 2010 2011 2012 2013 2014 2015 2016

38 37 38 37.8 38.9

64.6 63.8 62.5

68.3

36 36

39 39

*

**

*Prior to FY 2013, this measure tracked the percentage of patients with BP <130/80. **Minor logic change in FY 2016 to include patients with only one BPrecorded during the report period.

Diabetes: Blood Pressure Control (<140/90)


FY16 69.2% 74.0% 67.3% 64.3% 69.3% 66.5% 63.0% 70.4% 67.8% 66.3% 70.8% 71.6%

FY15 64.7% 68.5% 51.1% 57.3% 63.0% 59.4% 58.0% 65.6% 63.7% 62.4% 63.1% 63.6%

N 2457 8704 4321 5665 4839 11997 5743 20104 17107 20629 5973 3139

0%

20%

40%

60%

80%

100%

Diabetes: Statin Therapy to Prevent Cardiovascular Disease Risk

AI/AN patients with diabetes who are statin therapy users or receive a prescription for statin therapy during the report period.

2016

61.9

0

20

40

60

80

100

PER

CEN

T

*

*New measure in FY 2016. Replaced the Diabetes: LDL Assessed measure.

Diabetes: Statin Therapy to Prevent CVD Risk


FY16 67.5% 59.3% 67.3% 64.0% 52.8% 60.3% 64.9% 63.5% 64.0% 58.0% 62.4% 67.6%

FY15

N 1733 5800 2948 3928 3273 8097 3945 13927 12381 12972 4195 1861

0%

20%

40%

60%

80%

100%

Diabetes: Nephropathy Assessment AI/AN patients with diabetes who have been assessed for nephropathy within the past

year.

PER

CEN

T

CRS Diabetes Audit

100

80

60

40

20

0

50 50

55 56.5

66.7 68.2

60.0 62 63.3

35 37

44

48

2008 2009 2010 2011 2012 2013 2014 2015 2016

*

* New baseline set to reflect measure change requiring UACR in FY 2014.

Diabetes: Nephropathy Assessment


FY16 61.0% 73.1% 66.3% 65.6% 63.9% 66.6% 64.0% 58.7% 68.6% 55.3% 66.2% 64.1%

FY15 58.4% 70.8% 57.9% 61.5% 58.4% 62.0% 59.3% 60.0% 69.9% 54.2% 60.9% 58.8%

N 2457 8704 4321 5665 4839 11997 5743 20104 17107 20629 5973 3139

0%

20%

40%

60%

80%

100%

Diabetes: Retinopathy AI/AN patients with diabetes who have been assessed for retinopathy within the past

year.

50 51 53 53.5

55.7 57.6

59.9 61.3

59.1

0

2015 2016

*Minor logic change in FY 2016 to exclude chart reviews and telephone calls from counting towards meeting the measure

20

40

60

80

100

PER

CEN

T

*

2008 2009 2010 2011 2012 2013 2014

Diabetes: Retinopathy


FY16 55.4% 72.1% 48.5% 60.9% 50.2% 46.2% 56.6% 62.8% 68.0% 56.2% 52.2% 64.5%

FY15 55.4% 75.0% 52.9% 58.1% 48.0% 53.5% 53.7% 64.0% 70.0% 57.9% 54.5% 61.5%

N 2447 8682 4315 5663 4832 11982 5735 20035 17082 20599 5968 3125

0%

20%

40%

60%

80%

100%

Dental: General Access AI/AN patients who have received dental services within the past year.

PER

CEN

T

100

80

60

40

20

25 25 25 26.9

28.8 28.3 28.8 29.2 28.7

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 49.0%

0

Dental: General Access


FY16 32.0% 36.6% 34.9% 29.8% 42.7% 21.2% 38.6% 21.9% 27.6% 25.2% 33.9% 44.7%

FY15 31.4% 34.2% 33.1% 30.9% 41.5% 24.7% 38.4% 21.5% 29.8% 25.4% 35.1% 34.8%

N 55951 74462 42560 57059 65754 129303 39311 192953 169520 172256 73975 20217

0%

20%

40%

60%

80%

100%

Dental: Sealants AI/AN children with intact dental sealants.

13.9 14.6 16.3

18.1

0

20

40

60

80

100 P

ER

CEN

T

*

2013 2014 2015 2016

*Prior to FY 2013, this measure tracked the number of intact sealants in AI/AN patients within the past year.

Dental: Sealants


FY16 23.7% 28.8% 17.2% 26.7% 19.2% 14.2% 25.3% 15.9% 11.3% 19.4% 16.6% 21.5%

FY15 22.1% 25.2% 14.1% 24.3% 18.3% 16.2% 25.2% 16.2% 8.6% 16.1% 17.0% 23.4%

n 14344 16396 11531 16387 17092 36662 9971 47510 42179 45211 17517 5180

0%

20%

40%

60%

80%

100%

Dental: Topical Fluorides AI/AN children with at least one topical fluoride treatment within the past year.

26.7 27.9 29.4

31.1

0

20

40

60

80

100

PER

CEN

T

*

2013 2014 2015 2016

*Prior to FY 2013, this measure tracked the number of patients receiving one or more fluoride applications during the report period.

Dental: Topical Fluorides 100%

0%

20%

40%

60%

80%


FY16 38.5% 49.9% 35.6% 41.1% 32.2% 23.7% 49.7% 26.6% 23.8% 27.9% 35.2% 38.4%

FY15 36.0% 47.6% 34.8% 39.8% 31.1% 27.3% 50.5% 26.3% 19.0% 26.0% 35.3% 37.7%

n 15322 17395 12320 17596 18054 39454 10570 50444 45023 48495 18547 5520

Immunizations: Influenza 6mo - 17yrs AI/AN patients (ages 6 months to 17 years) who have received the influenza vaccine

within the past year.

37.1

0

20

40

60

80

100

PER

CEN

T

HP 2020 Goal = 70.0%

*

2016

* New measure in FY 2016. One of two measures that replaced the Influenza 65+ measure.

Immunizations: Influenza 6mo – 17yr


FY16 27.8% 42.1% 29.5% 36.6% 23.2% 37.1% 33.5% 53.5% 30.7% 32.6% 37.3% 55.5%

FY15

N 15059 14515 9674 14393 14676 29366 9577 43940 37313 39247 15213 4675

0%

20%

40%

60%

80%

100%

Immunizations: Influenza 18+ AI/AN patients (ages 18+) who have received the influenza vaccine within the past

year.

38.7

0

20

40

60

80

100 P

ER

CEN

T

HP 2020 Goal = 70.0%

*

2016

* New measure in FY 2016. One of two measures that replaced the Influenza 65+ measure.

Immunizations: Influenza 18+


FY16 27.7% 43.2% 32.3% 41.8% 27.5% 35.1% 35.4% 47.8% 39.0% 36.3% 38.9% 52.8%

FY15

N 29843 37181 19534 26286 30067 55374 20863 92898 84595 73672 36026 9353

0%

20%

40%

60%

80%

100%

Immunizations: Pneumococcal AI/AN patients (age 65+) with pneumo vaccine after the age of 65 or a dose of pneumo

vaccine in the past five years.

TITLE

100

80

60

40

20

0

82 82 84

85.5 88.5 89.2

85.7 84.9 86.4

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 90%

*

*New baseline in FY 2014 due to measure logic change

Immunization: Pneumococcal 65+


FY16 82.7% 92.1% 80.7% 85.6% 78.8% 83.4% 80.8% 91.8% 87.8% 82.9% 83.6% 90.0%

FY15 83.5% 92.0% 74.4% 84.0% 76.8% 81.4% 80.5% 91.0% 85.8% 81.8% 79.6% 89.7%

N 3522 4691 2326 2904 3603 5113 2609 14559 11087 7771 4238 1000

0%

20%

40%

60%

80%

100%

Immunizations: Childhood (19-35 months) AI/AN patients (age 19-35 months) who have received the combined childhood

vaccination series (4:3:1:3*:3:1:4).

PER

CEN

T

100

80

60

40

20

0

78 79 79 75.9 76.8

74.8 75.4 73.3 72.3

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 80%

** ***

*

* 1 Varicella vaccine added to the series in FY 2010. **4 Pneumococcal conjugate vaccines were added to the series in FY 2011. ***In FY 2013, 3or 4 HiB vaccines were required depending on the brand.

Immunizations: Childhood (19-35 months)


FY16 81.1% 86.2% 63.7% 64.9% 59.0% 73.5% 64.7% 79.5% 76.4% 65.4% 64.1% 86.4%

FY15 73.8% 91.0% 67.1% 67.7% 59.2% 74.8% 62.7% 83.2% 75.7% 65.7% 64.6% 77.6%

N 1131 811 834 1193 1111 2338 675 3549 3055 3223 1009 338

0%

20%

40%

60%

80%

100%

Cancer Screening: Cervical (Pap Screen) AI/AN women age 24-64 who have received a Pap screen

within the previous three years, or age 30-64 years with a Pap screen in the past three years or a Pap Screen and an HPV DNA in the past five years.

PER

CEN

T

100

80

60

40

20

0

59 59 59 58.1 57.1

61.7

54.6 54.9 54.8

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 93.0%

*

**

*Prior to FY 2013, this measure included women age 21-64 with a Pap screen in the previous three years. In FY 2013, the measure included women age 24-64 **As of FY 2014,this measure includes women 24-64 with a Pap Screen in the past 3 years or women 30 to 64 with a Pap screen and an HPV DNA in the past 5 years.

Cancer Screening: Cervical (Pap Screen)


FY16 65.2% 63.9% 49.1% 48.1% 48.8% 45.1% 57.8% 56.6% 64.2% 49.1% 49.3% 59.1%

FY15 64.3% 66.8% 47.6% 50.9% 46.4% 47.1% 56.5% 54.3% 62.2% 50.0% 49.0% 58.3%

N 11058 15214 7118 9847 11547 22096 7264 36041 30926 31662 13351 4053

0%

20%

40%

60%

80%

100%

Cancer Screening: Breast (Mammography) AI/AN women (age 52-64) who have received mammography screening

within the previous two years.

PER

CEN

T

100

80

60

40

20

45 45 48

49.8 51.9

53.8 54.2 54.5 54.8

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 81.1%

0

Cancer Screening: Breast (Mammography)


FY16 63.0% 58.5% 55.7% 47.0% 47.7% 52.6% 60.0% 52.2% 71.3% 43.4% 46.5% 53.2%

FY15 63.6% 58.0% 48.7% 46.7% 46.0% 49.7% 54.7% 52.2% 68.2% 43.3% 46.1% 55.2%

N 3149 4173 2122 2791 3204 5393 2135 10641 9243 7897 4041 1019

0%

20%

40%

60%

80%

100%

Cancer Screening: Colorectal

AI/AN patients ages 50-75 who have received appropriate Colorectal Cancer Screening.

PER

CEN

T

100

80

60

40

20

0

29

33

37

41.7

46.1

35.0 37.5 38.6 39.6

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 70.5%

*

*Prior to FY 2013, this measure tracked the percentage of patients ages 51 to 80 years of age who received appropriate colorectal cancer screening, whichincluded double contrast barium enema. Beginning in FY 2013, a double contrast barium enema no longer counts toward meeting the measure.

Cancer Screening: Colorectal


FY16 60.5% 41.9% 41.3% 34.6% 32.4% 32.7% 45.6% 36.8% 50.5% 28.1% 39.7% 35.0%

FY15 59.3% 39.7% 34.2% 34.3% 31.2% 27.5% 42.7% 34.6% 49.4% 26.7% 38.5% 33.9%

N 9342 11872 6678 8241 9482 15897 6759 32021 27897 21983 12010 2874

0%

20%

40%

60%

80%

100%

Tobacco Cessation AI/AN tobacco-using patients who have received tobacco cessation intervention within

the past year or quit their tobacco use within the past year.

PER

CEN

T

100

80

60

40

20

0

21 24 25

29.4

35.2

45.7 48.2

52.1 50.4

2008 2009 2010 2011 2012 2013 2014 2015 2016

*

*Measure logic change in FY 2013 to include tobacco users in cessation

Tobacco Cessation


FY16 46.7% 64.3% 57.7% 51.4% 42.3% 49.5% 43.0% 39.1% 66.7% 39.0% 47.1% 26.8%

FY15 40.6% 64.8% 55.5% 57.0% 41.5% 48.4% 43.1% 43.1% 66.8% 44.7% 46.9% 17.9%

N 17366 8962 12740 15941 11040 34194 11449 17358 36726 21559 17051 2426

0%

20%

40%

60%

80%

100%

Alcohol Screening: Fetal Alcohol Syndrome (FAS) Prevention AI/AN women (age 14-46) who have been screened for

alcohol use within the past year.

PER

CEN

T

100

80

60

40

20

47

52 55

57.8

63.8 65.7 66 66.6 67.2

2008 2009 2010 2011 2012 2013 2014 2015 2016

*

*Prior to FY 2016, this measure tracked the percentage of AI/AN female patients ages 15-44 who received alcohol screening.

0

Alcohol Screening: FAS Prevention


FY16 73.1% 71.8% 59.8% 66.6% 60.8% 71.5% 78.9% 59.9% 76.3% 62.1% 59.8% 71.8%

FY15 74.6% 76.5% 55.5% 65.9% 57.2% 69.3% 76.8% 59.3% 72.0% 64.8% 58.5% 67.0%

N 11733 14561 7213 10432 12060 23983 7993 34375 33862 31981 13706 4053

0%

20%

40%

60%

80%

100%

Domestic Violence/Intimate Partner Violence Screening: AI/AN women (age 14-46) who were screened for domestic violence /intimate partner violence

within the past year.

PER

CEN

T

100

80

60

40

20

42

48

53 55.3

61.5 62.4 63.5 63.6 65.3

2008 2009 2010 2011 2012 2013 2014 2015 2016

*

*Prior to FY 2016, this measure tracked the percentage of female patients ages 15-40 who had received DV/IPV Screening in thepast year.

0

DV/IPV Screening


FY16 71.0% 70.1% 58.0% 63.8% 62.9% 68.9% 76.4% 56.9% 75.8% 59.3% 56.1% 72.5%

FY15 69.9% 75.1% 53.9% 62.8% 58.6% 67.6% 69.6% 53.3% 70.2% 60.3% 56.3% 67.0%

N 11733 14561 7213 10432 12060 23983 7993 34375 33862 31981 13706 4053

0%

20%

40%

60%

80%

100%

PER

CEN

T

100

80

60

40

20

35

44

52

56.5

61.9 65.1 66.0

67.4 67.9

2008 2009 2010 2011 2012 2013 2014 2015 2016

0

Depression Screening

AI/AN patients ages 18 and older who have been screened for depression or diagnosed

with a mood disorder within the past year.

Depression Screening


FY16 70.0% 76.2% 63.0% 65.9% 65.5% 73.1% 75.0% 59.5% 77.3% 61.9% 61.1% 75.1%

FY15 68.3% 78.2% 58.7% 66.8% 61.3% 71.9% 70.8% 59.2% 73.9% 65.0% 60.5% 69.4%

N 29843 37181 19534 26286 30067 55374 20863 92898 84595 73672 36026 9353

0%

20%

40%

60%

80%

100%

Childhood Weight Control (CWC) AI/AN children ages 2-5 years with a BMI at or above 95th percentile.

PER

CEN

T

100

80

60

40

20

24 25 25 24.1 24 22.8 22.8 21.8 22.3

2008 2009 2010 2011 2012 2013 2014 2015 2016

HP 2020 Goal = 9.4%

0

Childhood Weight Control 100%

0%

20%

40%

60%

80%


FY16 27.7% 19.1% 31.3% 24.7% 21.2% 22.4% 22.0% 19.6% 15.4% 24.8% 26.5% 30.8%

FY15 28.9% 18.2% 29.5% 24.9% 21.7% 21.2% 23.6% 19.2% 16.0% 25.1% 26.0% 27.1%

n 2105 1935 1427 1755 1896 3994 1421 4831 4721 5212 1891 603

HIV Screening Ever AI/AN patients who have ever received screening for HIV.

41.9

0

20

40

60

80

100

PER

CEN

T

*

2016

*New measure for FY 2016

HIV Screening Ever


FY16 40.2% 46.4% 38.7% 42.1% 24.3% 42.3% 39.8% 51.2% 35.6% 44.0% 36.8% 62.0%

FY15

N 37944 53248 28411 37417 44812 86223 26666 129834 115892 117354 52212 13932

0%

20%

40%

60%

80%

100%

CVD Prevention: Comprehensive Assessment Active CHD patients ages 22 and older with a comprehensive assessment

PER

CEN

T

100

80

60

40

20

30 32

35

39.8

45.4 46.7

52.3 55.0

65.7

2008 2009 2010 2011 2012 2013 2014 2015 2016

*

**

*Prior to FY 2013, this measure tracked the percentage of active IHD patients ages 22 and older with a comprehensive assessment and included patients with an LDL

in the previous five years (beginning in FY 2013, LDL required during report period to meet measure).**LDL Assessment removed from the numerator definition in FY

2016.

0

Comprehensive CVD Assessment


FY16 55.7% 74.9% 66.6% 61.0% 63.4% 69.5% 75.6% 51.3% 75.5% 59.3% 59.2% 43.6%

FY15 38.9% 68.1% 49.3% 50.1% 47.0% 52.2% 54.2% 38.9% 69.2% 53.0% 44.0% 31.6%

N 1570 1587 1728 1866 1101 4596 2203 3748 6466 2992 1933 250

0%

20%

40%

60%

80%

100%

Breastfeeding Rates AI/AN patients who, at the age of two months, were either exclusively or mostly

breastfed.

PER

CEN

T

100

80

60

40

20

29.0

35.1 35.7 35.2

2013 2014 2015 2016

0

Breastfeeding Rates


FY16 53.0% 46.9% 27.3% 30.3% 46.9% 27.6% 37.6% 41.1% 33.0% 28.5% 44.7% 28.2%

FY15 51.7% 53.5% 25.2% 29.6% 60.8% 27.4% 33.3% 40.3% 31.5% 33.4% 39.3% 31.1%

N 185 224 194 178 162 590 109 1024 801 878 114 103

0%

20%

40%

60%

80%

100%

Controlling High Blood Pressure (MH) AI/AN patients with diagnosed hypertension who have achieved blood pressure control

(<140/90).

PER

CEN

T

100

80

60

40

20

59.5 58.5 59.2

2014 2015 2016

0

Controlling High Blood Pressure (MH)


FY16 57.9% 64.9% 58.8% 52.0% 57.7% 57.8% 55.0% 60.8% 61.3% 56.5% 60.0% 62.9%

FY15 56.3% 62.3% 47.3% 51.0% 55.6% 56.2% 55.2% 60.7% 61.5% 58.5% 57.6% 63.0%

N 5899 8091 5276 5466 5998 14749 6502 20229 26895 18747 8271 2771

0%

20%

40%

60%

80%

100%

2016 Final National Dashboard (IHS/Tribal)

DIABETES 2015 Target 2015 Final 2016 Target 2016 Final 2016 Final Results

Good Glycemic Control 47.7% 47.4% 49.5% 46.9% Not Met

Controlled BP <140/90 63.8% 62.5% 65.0% 68.3% Met

Statin Therapy to Reduce CVD Riskc N/A N/A Baseline 61.9% Met

Nephropathy Assessed 60.0% 62.0% 61.1% 63.3% Met

Retinopathy Exam 60.1% 61.3% 61.6% 59.1% Not Met

DENTAL

Dental: General Access 27.9% 29.2% 29.3% 28.7% Not Met

Sealants 14.1% 16.3% 14.8% 18.1% Met

Topical Fluoride 26.4% 29.4% 28.3% 31.1% Met

IMMUNIZATIONS

Influenza Vaccination 6mo - 17yrsc N/A N/A Baseline 37.1% Met

Influenza Vaccination 18+c N/A N/A Baseline 38.7% Met

Pneumococcal Vaccination 65+ 85.7% 84.9% 87.3% 86.4% Not Met

Childhood IZ 73.9% 73.3% 76.8% 72.3% Not Met

PREVENTION (Cervical) Pap Screening 54.6% 54.9% 55.6% 54.8% Not Met

Mammography Screening 54.8% 54.5% 55.9% 54.8% Not Met

Colorectal Cancer Screening 35.2% 38.6% 38.7% 39.6% Met

Tobacco Cessation 46.3% 52.1% 49.1% 50.4% Met

Alcohol Screening (FAS Prevention)a 66.7% 66.6% Baseline 67.2% Met

DV/IPV Screeninga 61.6% 63.6% Baseline 65.3% Met

Depression Screening 64.3% 67.4% 67.2% 67.9% Met

CVD- Comprehensive Assessmenta 47.3% 55.0% 53.3% 65.7% Met

HIV Screening Everc N/A N/A Baseline 41.9% Met

Childhood Weight Controlb N/A 21.8% 22.8% 22.3% Met

Breastfeeding Rates 29.0% 35.7% 35.8% 35.2% Not Met

Controlling High Blood Pressure (MH) 59.5% 58.5% 60.6% 59.2% Not Met

Public Health Nursing Encounters 425,679 377,913 390,556 Pending N/A

Suicide Surveillanced 1,419 2,346 1,798 Pending N/A (forms completed)

aMeasure logic changes in FY 2016 Measures Met: 15

bLong-term measure; reported in FY 2016 Measures Not Met: 9

cNew measure as of FY 2016

dMeasure data is submitted from 11 Areas

M easures in red are GPRAMA measures

Documents

FY 2016 Government Performance and Results Act (GPRA)Tobacco Cessation and Childhood Weight Control decreased from 2015 performance but still met 2016 targets Pneumococcal Vaccination,